Ensign Peak Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $83.4M | Sell |
|
|||||
|
2025
Q1 | $135M | Sell |
|
|||||
|
2024
Q4 | $127M | Sell |
|
|||||
|
2024
Q3 | $121M | Buy |
|
|||||
|
2024
Q2 | $93.8M | Sell |
|
|||||
|
2024
Q1 | $125M | Sell |
|
|||||
|
2023
Q4 | $134M | Sell |
|
|||||
|
2023
Q3 | $203M | Sell |
|
|||||
|
2023
Q2 | $271M | Sell |
|
|||||
|
2023
Q1 | $311M | Buy |
|
|||||
|
2022
Q4 | $321M | Buy |
|
|||||
|
2022
Q3 | $311M | Sell |
|
|||||
|
2022
Q2 | $351M | Buy |
|
|||||
|
2022
Q1 | $286M | Buy |
|
|||||
|
2021
Q4 | $129M | Sell |
|
|||||
|
2021
Q3 | $150M | Sell |
|
|||||
|
2021
Q2 | $172M | Sell |
|
|||||
|
2021
Q1 | $173M | Buy |
|
|||||
|
2020
Q4 | $154M | Buy |
|
|||||
|
2020
Q3 | $95.1M | Buy |
|
|||||
|
2020
Q2 | $63.1M | Buy |
|
|||||
|
2020
Q1 | $55.8M | Sell |
|
|||||
|
2019
Q4 | $73.8M | Buy |
|